Loading...
Loading...
Among the 5 tracked institutional investors we monitor, CTSO (CYTOSORBENTS CORP) is held with a combined value of $2.01M across 3,258,098 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.41M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$2.01M
Total Shares Held
3,258,098
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.41M | 0.00% | New |
| 2 | BlackRock, Inc. | $443.41K | 0.00% | +1.6% |
| 3 | STATE STREET CORP | $90.21K | 0.00% | - |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $57.04K | 0.00% | +0.6% |
| 5 | CITADEL ADVISORS LLC | $6.12K | 0.00% | -92.8% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CTSO with a position worth $1.41M, representing 0.00% of their portfolio. In total, 5 institutional investors hold CTSO with a combined value of $2.01M.
In the most recent quarter, 1 fund opened a new position in CTSO. Additionally, 2 increased their holdings and 1 reduced their positions.
Institutional investors hold $2.01M worth of CTSO stock across 5 positions. The largest institutional holder is VANGUARD GROUP INC with $1.41M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CTSO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CTSO positions.